Division of Neonatology, Department of Pediatrics, University of Maryland Hospital for Children, Baltimore, Maryland, USA.
Alcohol Clin Exp Res. 2010 Jun;34(6):941-5. doi: 10.1111/j.1530-0277.2010.01168.x. Epub 2010 Apr 5.
Biomarkers to detect past alcohol use and identify alcohol-related diseases have long been pursued as important tools for research into alcohol use disorders as well as for clinical and treatment applications and other settings. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) sponsored a workshop titled "Workshop on Biomarkers for Alcohol-Induced Disorders" in June 2008. The intent of this workshop was to review and discuss recent progress in the development and implementation of biomarkers for alcohol use and alcohol-related disorders with a goal to formulate a set of recommendations to use to stimulate and advance research progress in this critical area of alcoholism research. Presentations at this workshop reviewed the current status of alcohol biomarkers, providing a summary of the history of biomarkers and the major goals of alcohol biomarker research. Moreover, presentations provided a comprehensive overview of the current status of several well-recognized biomarkers of alcohol use, a summary of recent studies to characterize novel biomarkers and their validation, along with perspectives and experiences from other NIH institutes and from other federal agencies and industry, related to regulatory issues. Following these presentations, a panel discussion focused on a set of issues presented by the organizers of this workshop. These discussion points addressed: (i) issues related to strategies to be adopted to stimulate biomarker discovery and application, (ii) the relevance of animal studies in biomarker development and the status of biomarkers in basic science studies, and (iii) issues related to the opportunities for clinical and commercial applications. This article summarizes these perspectives and highlights topics that constituted the basis for recommendations to enhance alcohol biomarker research.
长期以来,生物标志物一直被用作研究酒精使用障碍、临床和治疗应用以及其他领域的重要工具,用于检测过去的酒精使用情况和识别与酒精相关的疾病。美国国立酒精滥用和酗酒研究所(NIAAA)于 2008 年 6 月主办了一次题为“酒精引起的疾病生物标志物研讨会”的研讨会。本次研讨会的目的是审查和讨论生物标志物在酒精使用和与酒精相关的疾病中的开发和应用方面的最新进展,旨在制定一系列建议,以促进和推动这一关键领域的酒精研究的进展。本次研讨会上的演讲回顾了目前酒精生物标志物的状况,总结了生物标志物的历史和酒精生物标志物研究的主要目标。此外,演讲还全面概述了几种公认的酒精使用生物标志物的现状,总结了最近用于描述新型生物标志物及其验证的研究,以及来自 NIH 其他研究所、其他联邦机构和行业的观点和经验,涉及监管问题。在这些演讲之后,一个小组讨论集中讨论了本次研讨会组织者提出的一系列问题。这些讨论点涉及:(i)为促进生物标志物的发现和应用而应采取的策略相关问题,(ii)动物研究在生物标志物开发中的相关性以及生物标志物在基础科学研究中的现状,以及(iii)与临床和商业应用相关的问题。本文总结了这些观点,并强调了构成增强酒精生物标志物研究建议基础的主题。